Peptide Super-Agonist Enhances T-Cell Responses to Melanoma

Recent immunotherapeutic approaches using adoptive cell therapy, or checkpoint blockade, have demonstrated the powerful anti-cancer potential of CD8 cytotoxic T-lymphocytes (CTL). While these approaches have shown great promise, they are only effective in some patients with some cancers. The potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Galloway, Sarah A. E., Dolton, Garry, Attaf, Meriem, Wall, Aaron, Fuller, Anna, Rius, Cristina, Bianchi, Valentina, Theaker, Sarah, Lloyd, Angharad, Caillaud, Marine E., Svane, Inge Marie, Donia, Marco, Cole, David K., Szomolay, Barbara, Rizkallah, Pierre, Sewell, Andrew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425991/
https://www.ncbi.nlm.nih.gov/pubmed/30930889
http://dx.doi.org/10.3389/fimmu.2019.00319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425991/
https://www.ncbi.nlm.nih.gov/pubmed/30930889
http://dx.doi.org/10.3389/fimmu.2019.00319

Ejemplares similares